Keyphrases
Cardiovascular Function
100%
Breast Cancer Survivors
100%
Mutation Strategy
100%
BRCA1, BRCA2
100%
Doxorubicin
88%
Mutation Carriers
33%
Age-adjusted
22%
Breast Cancer Susceptibility Gene 1 (BRCA1)
22%
Left Ventricular Ejection Fraction
22%
Non-carriers
22%
Mutation Status
22%
Core Laboratory
11%
Non-associated
11%
Dose Effect
11%
In Vitro Study
11%
No Significant Difference
11%
Women with Breast Cancer
11%
Cancer Therapy
11%
Loss Function
11%
Adjusted Analysis
11%
Cardiac Function
11%
Single Center
11%
Cardiac Dysfunction
11%
Echocardiography
11%
VO2max
11%
Mean Standard Deviation
11%
Cardiopulmonary Exercise Testing
11%
Cardiotoxicity
11%
Doxorubicin-induced Cardiotoxicity
11%
Cardiovascular Fitness
11%
Germline BRCA1/2 mutation
11%
Medicine and Dentistry
Breast Cancer
100%
Cardiovascular Physiology
100%
BRCA1
100%
Doxorubicin
75%
In Vitro
16%
Cardiotoxicity
16%
Cardiac Muscle Cell
16%
Heart Left Ventricle Ejection Fraction
16%
Induced Pluripotent Stem Cell
16%
Cross Sectional Study
8%
Cancer Therapy
8%
Heart Function
8%
Echocardiography
8%
Exercise Test
8%
Biochemistry, Genetics and Molecular Biology
Cardiovascular Function
100%
BRCA1
100%
Induced Pluripotent Stem Cell
16%
Cardiac Muscle Cell
16%
Heart Left Ventricle Ejection Fraction
16%
Wild Type
8%
Germ Cell
8%
In Vitro Study
8%
Animal Model
8%
Heart Function
8%
Germline
8%
Cross Sectional Study
8%